Company Filing History:
Years Active: 2009
Title: Innovations of Reuven Izsak in Pharmaceutical Chemistry
Introduction
Reuven Izsak is a notable inventor based in Doar Na Mizrah Binyamin, Israel. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of aripiprazole crystalline forms. His work has implications for the treatment of various mental health conditions.
Latest Patents
Reuven Izsak holds one patent titled "Methods of preparing aripiprazole crystalline forms." This invention encompasses the crystalline forms of aripiprazole, methods for preparing these forms, and pharmaceutical compositions that include aripiprazole crystalline forms. This patent represents a crucial advancement in the formulation of medications.
Career Highlights
Izsak is associated with Teva Pharmaceutical Industries Limited, a leading global pharmaceutical company. His role at Teva has allowed him to contribute to innovative solutions in drug formulation and delivery. His expertise in pharmaceutical chemistry has been instrumental in the development of new therapeutic options.
Collaborations
Reuven Izsak has collaborated with notable colleagues, including Judith Aronhime and Ben-Zion Dolitzky. These collaborations have fostered a productive environment for innovation and have led to advancements in pharmaceutical research.
Conclusion
Reuven Izsak's contributions to the field of pharmaceutical chemistry, particularly through his patent on aripiprazole crystalline forms, highlight his role as an innovator in the industry. His work continues to impact the development of effective treatments for mental health conditions.